These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8216210)

  • 1. Decrease in cerebral inositols in rats and humans.
    Moats RA; Lien YH; Filippi D; Ross BD
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):15-8. PubMed ID: 8216210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scyllo-inositol depletion in hepatic encephalopathy.
    Lien YH; Michaelis T; Moats RA; Ross BD
    Life Sci; 1994; 54(20):1507-12. PubMed ID: 8190025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.
    Cordoba J; Gottstein J; Blei AT
    Hepatology; 1996 Oct; 24(4):919-23. PubMed ID: 8855198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.
    Häussinger D; Laubenberger J; vom Dahl S; Ernst T; Bayer S; Langer M; Gerok W; Hennig J
    Gastroenterology; 1994 Nov; 107(5):1475-80. PubMed ID: 7926510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Free aminoacids and cerebral lipids in the rat following porto-cava anastomosis].
    Vassanelli P; Stella GD; Pelizzo MR; Rizzi B; Bertani G
    Arch Sci Med (Torino); 1973; 130(3):198-202. PubMed ID: 17342915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic consequences of experimental portacaval shunts].
    Franco D; Castaing D; Bismuth H
    Pathol Biol (Paris); 1979 Apr; 27(4):192-6. PubMed ID: 379754
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat.
    Wasterlain CG; Lockwood AH; Conn M
    Neurology; 1978 Mar; 28(3):233-8. PubMed ID: 564477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of bromocriptine on brain levels of noradrenaline, dopamine and serotonin in experimental portosystemic encephalopathy].
    Arias J; Alsasua A; Estébanez E; López-Sánchez ML; Arias JI; García de Jalón PD; Durán Sacristán H
    Rev Clin Esp; 1983 Mar; 168(5):339-41. PubMed ID: 6867408
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical models of hepatic encephalopathy.
    Basile AS; Mullen K
    Curr Protoc Neurosci; 2001 May; Chapter 9():Unit9.3. PubMed ID: 18428551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ammonia on cerebral metabolism of rats with portocaval shunts.
    Gjedde A; Lockwood A; Duffy TE; Plum F
    Trans Am Neurol Assoc; 1976; 101():180-1. PubMed ID: 1028230
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain protein synthesis in rats with portacaval shunts.
    Helewski K; Konecki J
    J Physiol Pharmacol; 1994 Dec; 45(4):555-62. PubMed ID: 7727797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies of the pathomechanism of portal encephalopathy. I. Changes in monoamine oxidase (MAO) activity in the cerebral cortex and cerebellum of rats after portacaval shunt].
    Rokicki W; Rokicki M; Kamiński K; Peciak B; Gebska E
    Neuropatol Pol; 1989; 27(2):199-207. PubMed ID: 2626178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats.
    Dienel GA; Cruz NF
    Metab Brain Dis; 2014 Dec; 29(4):1041-52. PubMed ID: 24154686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
    Wikell C; Eap CB; Josefsson M; Apelqvist G; Ahlner J; Baumann P; Bengtsson F
    Chirality; 2002 May; 14(4):347-50. PubMed ID: 11968077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte transplants improve liver function and encephalopathy in portacaval shunted rats.
    Fogel WA; Stasiak A; Maksymowicz M; Kobos J; Unzeta M; Mussur M
    CNS Neurosci Ther; 2014 Jul; 20(7):685-91. PubMed ID: 24716845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain monoamine metabolism and behavior in portacaval-shunted rats.
    Bengtsson F; Gage FH; Jeppsson B; Nobin A; Rosengren E
    Exp Neurol; 1985 Oct; 90(1):21-35. PubMed ID: 2412877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficits in cortico-striatal synaptic plasticity and behavioral habituation in rats with portacaval anastomosis.
    Sergeeva OA; Schulz D; Doreulee N; Ponomarenko AA; Selbach O; Borsch E; Kircheis G; Huston JP; Häussinger D; Haas HL
    Neuroscience; 2005; 134(4):1091-8. PubMed ID: 16039790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts.
    Hawkins PA; DeJoseph MR; Viña JR; Hawkins RA
    J Appl Physiol (1985); 1996 Mar; 80(3):885-91. PubMed ID: 8964752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia and chronic hepatic encephalopathy: an in vivo PMRS study of the rat brain.
    Astore D; Boicelli CA
    MAGMA; 2000 Jul; 10(3):160-6. PubMed ID: 10873206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.